Tech Company Financing Transactions
Proteostasis Therapeutics Funding Round
F-Prime Capital, Genzyme Ventures and HealthCare Ventures participated in a $25.6 million funding round for Proteostasis Therapeutics. The round was announced on 6/30/2011.
Transaction Overview
F-Prime Capital (Stephen Knight)
Genzyme Ventures (Alan Walts)
HealthCare Ventures (Christopher Mirabelli)
Novartis Venture Fund (Lauren Silverman)
Company Information
Boston, MA 02135
USA
Management Team
Browse more venture capital transactions:
Prev: 6/30/2011: IntegriChain venture capital transaction
Next: 6/30/2011: EAT Club venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs